Concordance between the days-supply-PER and the days-supply-Rx in sample 2
| ICS, number of puffs/canister | Age 0–11 years | Age 12–64 years | ||||
|---|---|---|---|---|---|---|
| Number of prescriptions | Concordance (%; 95 CI) | Number of prescriptions | Concordance (%; 95 CI) | |||
| Correction factors | Correction factors | |||||
| Before | After | Before | After | |||
| Beclomethasone, 200 | 43 | 34.9; 30.2 to 39.9 | 51.2; 46.0 to 52.3 | 11 | 18.2; 11.7 to 27.2 | 81.8; 72.8 to 88.3 |
| Budesonide, 200 | 7 | 42.9; 31.1 to 55.5 | 57.1; 44.5 to 68.9 | 235 | 21.3; 19.5 to 23.1 | 60.0; 57.8 to 62.1 |
| Ciclesonide, 120 | 149 | 36.9; 34.3 to 39.6 | 40.3; 37.6 to 43.0 | 114 | 28.1; 25.3 to 31.0 | 75.4; 72.6 to 78.1 |
| Fluticasone, 60 | 2 | 100.0; 81.5 to 100.0 | 100.0; 81.5 to 100.0 | 72 | 70.8; 67.1 to 74.3 | 80.6; 77.2 to 83.5 |
| Fluticasone, 120 | 583 | 48.4; 47.0 to 49.8 | 63.8; 62.5 to 65.1 | 900 | 53.3; 52.2 to 54.5 | 77.9; 76.9 to 78.8 |
| Mometasone, 30* | 0 | – | – | 8 | 100.0; 94.6 to 100.0 | 100.0; 94.6 to 100.0 |
| Mometasone, 60* | 0 | – | – | 2 | 50.0; 28.5 to 71.5 | 50.0; 28.5 to 71.5 |
| Budesonide/formoterol, 120 | 5 | 60.0; 45.0 to 73.3 | 60.0; 45.0 to 73.3 | 306 | 57.8; 55.9 to 59.7 | 59.1; 57.2 to 61.0 |
| Fluticasone/salmeterol, 60 | 1 | 100.0; 68.7 to 100.0 | 100.0; 68.7 to 100.0 | 114 | 89.5; 87.4 to 91.3 | 95.6; 94.1 to 96.7 |
| Fluticasone/salmeterol, 120 | 20 | 55.0; 47.5 to 62.3 | 60.0; 52.5 to 67.1 | 92 | 78.3; 75.2 to 81.0 | 89.1; 86.7 to 91.1 |
| Mometasone/formoterol, 120* | 0 | – | – | 12 | 75.0; 65.8 to 82.4 | 75.0; 65.8 to 82.4 |
| All | 810 | 45.9%; 44.7% to 47.1% | 59.4%; 58.2% to 60.5% | 1866 | 52.7%; 51.9% to 53.5% | 74.2%; 73.5% to 74.9% |
*No correction factor developed for these three drugs in sample 1.
days-supply-PER, number of days of supply of the medication in each filled prescription, as recorded in the pharmacy electronic record; days-supply-Rx, number of days of supply of the medication in each filled prescription, as calculated from the dosage written on the original prescription; ICS, inhaled corticosteroid.